Organisation paid for research Program year 2025 Source: CMS Open Payments

Arthur Snyder MD PC

Neither a doctor nor a teaching hospital

Research payments

$523,678

76 payments

Through program year 2025, Arthur Snyder MD PC is reported as receiving $523,678 in research payments, across 76 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$65,012	2
2023	Research	$54,322	4
2022	Research	$12,055	6
2020	Research	$22,159	3
2019	Research	$370,130	61

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $314,554 65 payments
Novartis Pharmaceuticals Corporation $115,947 3 payments
GlaxoSmithKline, LLC. $93,177 8 payments

Studies the money was for Research payments · program years 2019–2025

M15-554 $110,582 11 payments
M15-925 $103,902 10 payments
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, $93,177 8 payments
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjogrens syndrome $62,448 1 payment
A Randomized, Double-Blind, Placebo Controlled, 3-Arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's Syndrome (Neptunus-2) $53,499 2 payments
M13-538 $28,702 10 payments
M14-465 $25,459 10 payments
M15-555 $18,253 8 payments
A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs $15,441 9 payments
M15-572 $12,214 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.